Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody

Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody

US Patent 6455043 · Granted Sep 24, 2002

Estimated economic value: $80,615,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of diffuse large-cell lymphoma with anti-CD20 antibody2019
Combination therapies for B-cell lymphomas comprising administration of anti-CD22018
Treatment of pemphigus2018
Treatment of diffuse large-cell lymphoma with anti-CD20 antibody2016
Combination therapies for B-cell lymphomas comprising administration of anti-CD22016
Treatment of diffuse large-cell lymphoma with anti-CD20 antibody2014
Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody2013
Treatment of vasculitis2013
Combination therapies for B-cell lymphomas comprising administration of anti-CD22012
Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies2012
Treatment of autoimmune diseases2010
Treatment of hematologic malignancies associated with circulating tumor cells us2010